Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use therof
US10227346B2 · kind B2 · utility
1Cited by
6References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 6, 2018 |
| Grant date | Mar 12, 2019 |
| Priority date | — |
| Expiry date | Feb 6, 2038 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB65D2577/205
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methyl- and trifluoromethyl-substituted pyrrolopyridines, pharmaceutical compositions thereof, methods of modulating RORγ activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such pyrrolopyridines and pharmaceutical compositions thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.